| Financial Year |
March 31 2023 |
| Monetary Funds |
71,487,870,000.00 |
| Held-for-trading Financial Assets |
4,224,290,000.00 |
| Notes Receivable |
5,710,180,000.00 |
| Accounts Receivable |
79,775,022,000.00 |
| Advances to Suppliers |
35,897,027,000.00 |
| Other Receivables |
26,747,421,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
118,000.00 |
| Dividend Receivable |
134,636,000.00 |
| Inventories |
65,226,171,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,240,564,000.00 |
| Other Current Assets |
12,160,778,000.00 |
| Total Current Assets |
407,941,217,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
35,604,995,000.00 |
| Long-term Equity Investment |
40,562,385,000.00 |
| Investment Properties |
720,932,000.00 |
| Fixed Assetes |
43,762,450,000.00 |
| Under-construction Projects |
17,795,748,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
70,074,978,000.00 |
| R&D expenses |
74,045,000.00 |
| Goodwill |
2,598,015,000.00 |
| Long-Term Deferred and Prepaid Expenses |
965,198,000.00 |
| Deferred Income Tax Assets |
2,544,523,000.00 |
| Other Non-Current Assets |
61,081,378,000.00 |
| Sub-Total of Non-Current Assets |
290,447,234,000.00 |
| Total Assets |
698,388,451,000.00 |
| Short-Term Loans |
34,078,363,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
15,120,643,000.00 |
| Accounts Payable |
170,920,711,000.00 |
| Accounts Received In Advance |
39,736,000.00 |
| Employee Compensation Payable |
2,728,765,000.00 |
| Taxes Payable |
5,917,272,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
857,991,000.00 |
| Other payables |
38,806,764,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,025,709,000.00 |
| Other Current Liabilities |
5,641,294,000.00 |
| Sub-Total of Current Liabilities |
356,023,813,000.00 |
| Long-term Loans |
144,812,143,000.00 |
| Bonds Payable |
10,000,000,000.00 |
| Long-Term Accounts Payable |
1,710,949,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
85,673,000.00 |
| Deferred Income Tax Liabilities |
1,771,174,000.00 |
| Other Non-Current Liabilities |
1,122,363,000.00 |
| Sub-Total of Non-Current Liabilities |
170,043,080,000.00 |
| Total Liabilities |
526,066,893,000.00 |
| Paid-In Capital(Or Share Stock) |
41,691,164,000.00 |
| Capital Surplus |
17,200,348,000.00 |
| Surplus Reserve |
7,548,094,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
25,684,524,000.00 |
| Minority Stockholder's Interest |
68,983,901,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
103,337,656,000.00 |
| Owner's Equity（Stockholder's Equity） |
172,321,557,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
698,388,451,000.00 |
